Social Capital Suvretta I (NASDAQ:DNAA) announced in an 8-K this afternoon that its shareholders have approved its combination with digital medicine company Akili Interactive at a special meeting held yesterday.
Approximately 99.09% of DNAA shareholders opted to redeem their shares, leaving just 227,252 shares left in the SPAC’s trust. This marks the 4th highest redemption amount throughout 2022 thus far trailing behind Agrico, CC Neuberger Principal Holdings II, and ITHAX, which saw redemptions of 99.8%, 99.4% and 99.4%, respectively.
Akili was able to raise more than $163 million from the transaction, before deducting transaction expenses and advisory fees, which, together with cash on hand, the company expects will be sufficient to fund at least 24 months of business operations. Proceeds from the deal will be used to fund the commercial launch of EndeavorRx, a prescription digital therapeutic for pediatric ADHD, as well as its expansion into further patient populations.
Social Capital Suvretta I backed the deal with a $162 million PIPE at $10 per share. Social Capital put up $100 million of the PIPE with the remaining $62 million split among Suvretta Capital’s Averill strategy, Apeiron Investment Group, Temasek, PureTech Health, Polaris Partners, Evidity Health Capital, JAZZ Venture Partners, and Omidyar Technology Ventures.
The newly formed company, Akili, Inc., is now expected to start trading on The Nasdaq under the new ticker symbol “AKLI” on August 22, 2022.
The SPAC announced the $1 billion deal with Akili earlier this year on January 26, 2022. Boston-based Akili is developing a range of video games designed to serve as digital therapeutics for patients suffering from ADHD, autism, multiple sclerosis and other cognitive ailments.
Advisors
- Morgan Stanley & Co. LLC and Cowen and Company, LLC are serving as financial advisors to Akili.
- Morgan Stanley, Credit Suisse, and Cowen are serving as co-placement agents to SCS with respect to the portion of the PIPE financing raised from non-insider qualified institutional buyers and institutional accredited investors.
- Morgan Stanley, Credit Suisse, and Cowen are not acting as agents or participating in any role with respect to, and will not earn any fees from, the portion of the PIPE financing raised from insiders and individual investors.
- Credit Suisse and Cowen are serving as capital markets advisors to Akili.
- BofA Securities, Inc. is acting as capital markets advisor to SCS.
- Goodwin Procter LLP is serving as legal counsel to Akili.
- Wachtell, Lipton, Rosen & Katz is serving as legal counsel to SCS.
- Skadden, Arps, Slate, Meagher & Flom LLP is serving as legal advisor to the PIPE placement agents.
Terms Tracker for the Week Ending December 20, 2024 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. * We will be skipping next week’s Terms Tracker post while we work on putting together our “2024 Year End Review”. You can find 2023’s...
Four Leaf Acquisition Corporation (NASDAQ:FORL) has entered into a definitive agreement to combine with Chinese technology firm Xiaoyu Dida for undisclosed terms. The Guangzhou, China-based firm produces software and hardware for smart car washing systems. The parties have set December 31, 2025 as the initial outside date and the combined company is expected to trade...
At the SPAC of Dawn SPACs are back on the board with a new deal announcement, which is the first in a little over two weeks. This brings the fourth quarter count on fresh deals to a still-meager nine after 27 were announced in the third quarter. By contrast, this quarter has still seen more...
Range Capital Acquisition Corp. (NASDAQ: RANGU) announced the pricing of its $100 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “RANGU”, Friday, December 20, 2024. The new SPAC intends to take a generalist approach in searching for a business combination, but will seek opportunities in capital constrained...
SPAC Deja Vu There’s been a lot of talk this year in the SPAC market about how it’s finally reverting back to a healthier version of deal flow and the comparison is always, “….like 2019”. In fact, in 2019, Trump was in office and there were 59 SPAC IPOs priced. As of this morning, Trump...